August 7, 2026
Quantum BioPharma’s Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement
August 7, 2026
Quantum BioPharma Advances Dual Strategy for Neurological Health, Targeting MS and Alcohol Misuse
August 7, 2026
Spanish Case of Pork Tapeworm Mimicking Brain Cancer Underscores Diagnostic Challenges and Need for New Treatments
August 6, 2026
Liquid Biopsy Could Predict Immunotherapy Response in Advanced Lung Cancer, Study Suggests
August 3, 2026
Quantum BioPharma Reports Encouraging Preliminary Data from Midpoint of MS Imaging Study
August 3, 2026
Independent Research Highlights Potential for Broader Filovirus Vaccines, Supporting GeoVax’s MVA Platform
July 30, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC Cancer Therapy Platform
July 30, 2026
Instinct Bio Partners with INVITRX to Launch GENREVER in U.S. and Boost Indonesia Regenerative Medicine
July 29, 2026
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms
July 29, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as Chief Scientific Officer to Advance BiTAC(R) Cancer Therapy Platform
July 29, 2026
Nearly 23 Million US Adults With High Blood Pressure May Need Medication Under New Guidelines
July 28, 2026
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases
July 28, 2026
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial, Explores Commercial Revenue from unbuzzd
July 28, 2026
Regentis Biomaterials Advances GelrinC Cartilage Repair Platform Amid Strategic Industry Validation
July 28, 2026
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases
July 27, 2026
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial, Balances Pipeline with Commercial Product unbuzzd
July 27, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Partnership Milestones
July 27, 2026
Culturally Tailored Navajo Meals Reduce Heart Failure Hospitalizations by More Than Half, Study Finds
July 27, 2026
Tonix Pharmaceuticals Schedules Q2 2026 Earnings Call Amid Expansion of CNS and Immunology Pipeline
July 25, 2026
New Framework for Behçet’s Spectrum Disorders Could Improve Diagnosis and Treatment in Children
July 24, 2026
NanoViricides Raises $3.8 Million in Registered Direct Offering to Fund Antiviral Drug Development
July 23, 2026
VERAXA Biotech Receives Regulatory Support from Germany’s Paul-Ehrlich-Institute for BiTAC®-TCE Platform
July 23, 2026
Recent Disease Outbreaks Expose Critical Gaps in U.S. Public Health Systems, Expert Says
July 23, 2026
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods
July 23, 2026
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Development
